Ampio Pharmaceuticals, Inc. financial data

Symbol
AMPE on OTC
Industry
Pharmaceutical Preparations
Location
9800 Mount Pyramid Court, Suite 400, Englewood, CO
State of incorporation
DE
Fiscal year end
December 31
Former names
Chay Enterprises, Inc. (to 3/17/2010)
Latest financial report
10-K - Q4 2023 - Mar 27, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 339 % -38.2%
Debt-to-equity 43.6 % +21.2%
Return On Assets -104 % -46.8%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 1.14M shares -92.5%
Common Stock, Shares, Outstanding 833K shares +3.57%
Entity Public Float 3.4M USD -90.9%
Common Stock, Value, Issued 0 USD
Weighted Average Number of Shares Outstanding, Basic 810K shares +7.5%
Weighted Average Number of Shares Outstanding, Diluted 810K shares +7.5%

Income Statement

Label TTM Value / Value Unit Change %
Research and Development Expense 2.44M USD -72.6%
General and Administrative Expense 7.08M USD -38.3%
Nonoperating Income (Expense) 942K USD -84.3%
Net Income (Loss) Attributable to Parent -8.63M USD +47.2%
Earnings Per Share, Basic -10.7 USD/shares +50.8%
Earnings Per Share, Diluted -10.7 USD/shares +63.6%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 4.09M USD -67.7%
Assets, Current 5.74M USD -57%
Property, Plant and Equipment, Net 0 USD -100%
Operating Lease, Right-of-Use Asset 0 USD -100%
Assets 5.74M USD -57.8%
Accounts Payable, Current 750K USD +673%
Liabilities, Current 2.38M USD +99.3%
Operating Lease, Liability, Noncurrent 0 USD -100%
Liabilities 2.38M USD +32.1%
Retained Earnings (Accumulated Deficit) -243M USD -3.67%
Stockholders' Equity Attributable to Parent 3.36M USD -71.5%
Liabilities and Equity 5.74M USD -57.8%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -2.3M USD +53.5%
Net Cash Provided by (Used in) Financing Activities 0 USD
Net Cash Provided by (Used in) Investing Activities 0 USD
Common Stock, Shares Authorized 300M shares 0%
Common Stock, Shares, Issued 833K shares +3.57%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -2.3M USD +54.5%
Deferred Tax Assets, Valuation Allowance 56.4M USD +3.7%
Operating Lease, Liability 274K USD -55.4%
Depreciation 1.13M USD +31.9%
Payments to Acquire Property, Plant, and Equipment 0 USD -100%
Lessee, Operating Lease, Liability, to be Paid 280K USD -56.5%
Property, Plant and Equipment, Gross 9.43M USD -12.7%
Operating Lease, Liability, Current 274K USD -19.4%
Lessee, Operating Lease, Liability, to be Paid, Year Two 280K USD -23.1%
Lessee, Operating Lease, Liability, to be Paid, Year One 280K USD -23.1%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 6K USD -80%
Deferred Tax Assets, Operating Loss Carryforwards 51.9M USD +3.4%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 10M shares 0%
Preferred Stock, Shares Outstanding 0 shares
Depreciation, Depletion and Amortization 908K USD -53.4%
Deferred Tax Assets, Net of Valuation Allowance 0 USD
Share-based Payment Arrangement, Expense 159K USD -83.3%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%